CLINICAL_TRIALS
research
· 2025-10-24
Clinical Trial Update: Persona Ti-Nidium Post-Market Clinical Follow-up [NA]
Summary
Zimmer Biomet's Persona Ti-Nidium post-market follow-up trial is active but not recruiting, focusing on knee-related conditions such as osteoarthritis and relat…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zimmer Biomet | Conditions: Knee Pain Chronic, Osteoarthritis | NA | Status: ACTIVE_NOT_RECRUITING